Anti-inflammatory treatment for severe pneumonia in the ICU
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the intensive care unit (ICU) and have been there for less than 48 hours.
- You are at least 18 years old.
- You have been diagnosed with severe community-acquired pneumonia (a serious lung infection you got outside the hospital).
- You do not have another type of pneumonia that started while in the hospital or on a breathing machine.
- You are not in septic shock (extremely low blood pressure that does not improve with fluids).
- You are not allergic to corticosteroids (steroids) and do not have a condition that makes them unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how severe pneumonia that starts outside the hospital is treated and how common it is. If you join, doctors will collect medical information (and possibly a blood sample) to learn better ways to care for people with this condition.
This trial tests whether giving steroids (anti-inflammatory medicines) to people with a severe lung infection called Pneumocystis pneumonia (PJP) can improve outcomes. It is for patients who are in the ICU and do not have HIV, which is a different group than typical PJP patients.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
This trial tests whether steroids (corticosteroids) can help adults with severe pneumonia caused by adenovirus (a common virus) who are in the ICU. The goal is to see if steroids reduce inflammation and improve recovery.
This trial tests whether giving corticosteroids (anti-inflammatory medicines) to adults with severe psittacosis pneumonia in the ICU can help them recover better. It aims to see if this treatment reduces the need for breathing support or improves survival.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
Hear when a new Severe Community-acquired Pneumonia (sCAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.